IPO Year In Review: Late Rally Gives 50 Newly Public Biopharma Firms A 45.1% Average Return

 
• By Mandy Jackson
  
IPO Initial Private Offering Stock Market Ticker Building 3d Illustration
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business